{"name":"Blau Farmaceutica S.A.","slug":"blau-farmaceutica-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Filgrastine","genericName":"Filgrastine","slug":"filgrastine","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Filgrastine","genericName":"Filgrastine","slug":"filgrastine","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPRmgzb1R6MEw5V1BIQUhIbllTaWZMb050ZUYyNTdTbWxBdXItTFJWXzZDaFVqSHJlMV85enExYUNMQmR4Y2FMYnZ6TTlHLWROSWNMTEhXZGMtVWZONEtJbDVfRVI4dW5ZVUdQUDhoX0p1U1VwbjZwUFRJOTF1UjNuNTgyeHl2dFJBcEFfbGJ5VUZFVk4tVjNnRHBFSUFYYi1WNnBoeUxDdzEwWkF4QldxeDV5VXQ5RkNHWVE?oc=5","date":"2026-04-07","type":"patent","source":"AD HOC NEWS","summary":"Blau Farmacêutica S.A. stock: Biosimilars powering growth in Latin America - AD HOC NEWS","headline":"Blau Farmacêutica S.A. stock: Biosimilars powering growth in Latin America","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxNX0VUUWhoaFZoMTQ3N0lkWDkxMnJIRjZVUU9zQ0dISmhRWlpVRXJfSTZtTFFmal9FZ2xrd3hSMXNuaDVmUkg3QmNQd2h6ekNJakdQU2FTSWhTcFY2eWhzUXAwMUR3bnFmcFpnVVMxWXZFTE9QRVFwM2VwZXN3UHptQXB3aU5lNlhfTXFHbDZzOEFuYlJMZW02UGtINUpXSllkMkJWRHkwV1VIZ2dTVXpfeHJrQ3RZMjhHc21Zc2RpSWpJSEFzck1rQ05tY1RVektYdHlhWFlWZ2I1NFd6dXhMel94VTkxSjVaNXMzYzh5TkQ1NmZFcF9ORU9ON3NjSElRTDRVVHZhWEFUZ2drY2xaSWZjeDhfMEJy?oc=5","date":"2026-04-07","type":"patent","source":"TradingView","summary":"Blau Farmacêutica: Biosimilars and mAbs drive transformational growth, supported by expansion and innovation - TradingView","headline":"Blau Farmacêutica: Biosimilars and mAbs drive transformational growth, supported by expansion and innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPMGNmTXFfVkEzOEJSS05Ka0ROU0JibnZNM3EwZzREX0dPaVFtUmR4Smh2TzFoNnBPMG85TVkxQ29Ba3BFMlVyc0RQc3IyWkVwZ3B6LTNKTUtyUVJlUkw4WmFqTGF5US1sVnRMRkktSTloR0I3d1RWcmphWTJfRDVJZnVZckVsT01fOEl4aTM4MTNsblZwOXhOdHlNVXVZY3I3VWd1Zm8yWDU4b0IxdjRtTmxmSk5VR2JnM1E?oc=5","date":"2026-04-06","type":"pipeline","source":"AD HOC NEWS","summary":"Blau Farmacêutica S.A. stock: What investors need to know now - AD HOC NEWS","headline":"Blau Farmacêutica S.A. stock: What investors need to know now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPMm9MVHRyV0lLcWg5MG90YzlZeHc0SEtUeEQ3M2RkUlhIX3JOZVJfbVJ1cmJ4OFZLUHl6bjgzaXNORXctNk43eGRfWXVYWHN6elZKN3RubGJWaFJlWThiV0ZVSExjR3h0WUR0VkduZnRZMjE3WThyamxiR2hPSkw4MXItT0lzQ1RfejJuX1pFM3drQU14VUUtSWJULWpXa2xGVjh6YzVTXy1MenhQZk9wY2tXQnN2UGpGWVJ0YzV0OA?oc=5","date":"2026-04-01","type":"pipeline","source":"AD HOC NEWS","summary":"Blau Farmacêutica S.A. Stock: A Brazilian Pharma Player's Growth Story and Investor Opportunities i - AD HOC NEWS","headline":"Blau Farmacêutica S.A. Stock: A Brazilian Pharma Player's Growth Story and Investor Opportunities i","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOdzdCWmt3V2hnN1c3T25HMmlpT3BNY3hLTzVESXk2cTYxcVp3X2E4WWVJTlRMbmc1TTVwaEVyMDZWRzluTnNXTm1TSWVNdVYtdS1xUC1QSTFRN1BTV1I2YmdGS3RTYi1JOTJQUkpOWWlsNVJHcmZjbjNlXzlhNEtkQnA0aTJmT05MXzg0aHBfNzl4TW9aVC1KNVRDd0pZTEFfU3lvajEzeF9ZWFVLMm5kdV9TSEFQajd5STRqT2JUNWc?oc=5","date":"2026-03-22","type":"pipeline","source":"AD HOC NEWS","summary":"Blau Farmacêutica S.A. stock faces headwinds amid Brazil pharma sector slowdown - AD HOC NEWS","headline":"Blau Farmacêutica S.A. stock faces headwinds amid Brazil pharma sector slowdown","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNVXBERUI3M1VvdVBsVlJ3Q2NKQXAzXzA2emlyd05rbGtZWmZ5YTB2N1BZU1J0WkQxc1lKcS1PNERVSHNYR2pESk53NE1kZjUtZnZuSjBTTXRlLUN1QVdsdlF4THpWUjJXNnQ3VmVMU3l3b1ROdm5mRXR4aXlxcG1XMi1uSWR3OVNITGtSa21vQzhuWHE0YzBnSXctbGp5YjlJR1Z2dmlISGNLWFlTaEJNYmt1X2VEdUU4bjRR?oc=5","date":"2026-03-18","type":"earnings","source":"Investing.com","summary":"Blau Farmacêutica 4Q25 slides: margin gains offset revenue miss - Investing.com","headline":"Blau Farmacêutica 4Q25 slides: margin gains offset revenue miss","sentiment":"negative"},{"url":"https://news.google.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?oc=5","date":"2026-01-15","type":"pipeline","source":"simplywall.st","summary":"Blau Farmacêutica S.A.'s (BVMF:BLAU3) largest shareholder, CEO Marcelo Hahn sees holdings value fall by 13% following recent drop - simplywall.st","headline":"Blau Farmacêutica S.A.'s (BVMF:BLAU3) largest shareholder, CEO Marcelo Hahn sees holdings value fall by 13% following re","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBWVUZ6YUlPY1Y4dEhkQ0lvdlhXXzZKRnM1ZVkxc29UdXRvRmo2UjVyN1dldEJ5ZzljRmliUmVMNmRMYzUwTVUyNDdjVjNtWDhBSHpQZlNHWXNSbjR6WFFQa3dJQTFEb1JFaDNxTmp3?oc=5","date":"2024-04-29","type":"pipeline","source":"KED Global","summary":"Korean botox sales gain momentum in US, China - KED Global","headline":"Korean botox sales gain momentum in US, China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNM0llNEtlZUJ3MHBCaWJoenNJT2pSalV0bGNpdWxYZDdjbV9VQlJlaFAwQzVrcExMTllHM1h6d1k4djFadnphTEU5ZnJkVVVIVjEwcll0MkJyaFZiTUszblZDZFdNamJnSXdmUG9ja0tTOWxXYWdXRy1fRm9zYkFGNFYxdEp5TXU1NzFORF9UMi1uOHV4eWtMVXU2ek53UEljeEJKTU5sT3RUQQ?oc=5","date":"2021-12-22","type":"pipeline","source":"Reuters","summary":"Brazilian companies hear the siren's call of U.S. stock exchanges - Reuters","headline":"Brazilian companies hear the siren's call of U.S. stock exchanges","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOM2UtZm5VWUVnTXpEWHo2T2k5Z19HMFVGX2dsdG13dlRCeVlHZVotZjR0YXVIUVg3bTg2UzM3dW9RSmRKWkN1T01YMW42MjNtMWlnSnRXTEVSNngta0RrUEFZNnFhbHRJZmUwYlpOY3JsTFU0eWtCN2NxUTRRWFhCU0Nn?oc=5","date":"2021-11-19","type":"regulatory","source":"Generics and Biosimilars Initiative","summary":"Biosimilars approved in Chile - Generics and Biosimilars Initiative","headline":"Biosimilars approved in Chile","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}